Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy

NCT05040932 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: YH004

Sponsor

Eucure (Beijing) Biopharma Co., Ltd